Poor quality ICSR data impacts the ability to conduct safety surveillance activities and forces regulators and independent groups to question the overall quality of the pharmacovigilance system. Learn best practices and recommendations that can be employed to improve case quality, avoid feedback from regulators and independent groups, and facilitate data accuracy for safety surveillance and signal detection.
0 Comments